Calmark () | Spotlight

Calmark is active in medical technology. The company is specialised in the development of diagnostic equipment for infants. The technology is based on a proprietary platform and is used for analysis during the first weeks after birth. The instrument is used as a biomarker to study blood count. The company was founded in 2007 and is based in Karlstad.

Quotes for Calmark Sweden AB

+/-
%




()

Board

CEO

Anna Söderlund

Chairperson of the Board

Mathias Karlsson

Board

Anna-Karin Edstedt Bonamy
Kjersti Berg Marthinsen
Mathias Karlsson
Stefan Blomsterberg

Articles of association

News

2024-03-06 17:09:25 Calmark Sweden AB:s konkursansökan beviljad och konkursförvaltare utsedd
2024-03-05 08:53:10 Calmark Sweden AB (publ) ansöker om konkurs
2024-02-20 08:00:00 Bokslutskommuniké 2023 och delårsrapport fjärde kvartalet (Q4) 2023
2024-02-07 16:25:53 Calmark extends the shelf life of the test cassettes to 2 years.
2024-02-07 16:25:53 Calmark förlänger hållbarheten på testkassetterna till 2 år

Show More

Analysis

2023-01-03 Redeye: Calmark: Redeye Ceases Coverage - Redeye
2022-11-23 Redeye: Calmark Q3 2022: Our Comments - Redeye
2022-11-14 Redeye: Calmark: Management Changes - Redeye
2022-09-30 Kalqyl: Calmark: Tillväxtresan kan starta - Kalqyl
2022-08-24 Redeye: Calmark Q2: Anticipated Rights Issue Announced - Redeye

Videos

Annual reports, prospectus etc.